EcoDrugPlus

Ensembl ID : ENSAMXG00000035572
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSAMXG00000008217
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSAMXG00000031217
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSAMXG00000032898
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSAMXG00000003341
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSAMXG00000013451
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSAMXG00000007634
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSAMXG00000012988
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSAMXG00000013686
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSAMXG00000025836
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSAMXG00000029856
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSAMXG00000042421
Gene Symbol: -
Cross references: -
230 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).